You are here

Mesenchymal Stem Cells

Enhancing Bone Regeneration by Silencing Smurf1 in MSCs

The associated detrimental effects of the administration of high doses of bone morphogenetic proteins (BMPs) required to promote osteogenesis in orthopedic applications currently hinders many clinical applications.

Stem Cell Therapy in Idiopathic Pulmonary Fibrosis

A recent first‐in‐human clinical trial led by Vladimir Baklaushev (Federal Research Clinical Center FMBA of Russia, Moscow, Russi

The Fate of Adipose-Derived Mesenchymal Stem Cells

While the exogenous administration of adipose‐derived mesenchymal stromal cells (ASCs) holds great promise as a treatment strategy for wound healing by promoting tissue repair and regeneration, the best route of administration remains undefined.

PCK2 Promotes Osteogenesis by MSCs via Autophagy

The degradation products from autophagy can serve as an optional nutrient supply for cell survival and differentiation, making autophagy a suitable energy‐refueling process during osteogenesis by mesenchymal stem cells (MSCs).

TAK1 is a Critical Regulator of BM-MSC Proliferation

While bone marrow‐derived mesenchymal stem cells (BM-MSCs) represent a highly utile cell type for cell transplantation therapy, the molecular network underlying BM-MSC proliferation remains poorly understood. Now, researchers led by Takeshi Teramura (Kindai University, Osaka, Japan) report TGFβ‐activated kinase (Tak1) as a critical regulator of BM-MSC proliferation.

Understanding Metabolism to Improve MSC Survival

To develop the next generation of cell‐delivery materials and methods, we must have a better understanding of the metabolic switches mesenchymal stem cells (MSCs) experience upon transplantation. By designing treatment strategies with cell metabolism in mind, we may improve survival and the overall therapeutic potential of MSCs.

MSC-Derived Extracellular Vesicle Therapy

A new review article from the laboratory of David S.

Bmi1 Overexpression in MSCs - A Novel Means to Treat Aging-related Disease?

Research showing that Bmi1 overexpression exerts anti‐aging effects may permit the development of enhanced mesenchymal stem cell-based therapeutic approaches

Assessing iPSC-derived MSCs as a Therapeutic Approach to Obesity‐Associated Kidney Injury

Researchers hope that comparing mesenchymal stem cells from various sources will drive the development of an treatment for obesity‐related kidney injury

New Autologous MSC Trial in Osteoarthritic Patients Suggests Safety and Hints at Efficacy

A new clinical trial assesses autologous bone marrow-derived mesenchymal stem cell therapy in twelve patients with moderate to severe knee osteoarthritis



Subscribe to RSS - Mesenchymal Stem Cells